Abbott Laboratories (NYSE:ABT) on 09/13/2018 declared a dividend of $ 0.2800 per share payable on November 15, 2018 to shareholders of record as of October 15, 2018.

Abbott Laboratories (NYSE:ABT) has paid dividends since 1926, has a current dividend yield of 1.67% and has increased its dividends for 4 successive years.

Abbott Laboratories's market cap is $ 117,486,743,430 and has a PE ratio of 131.31. The stock price closed yesterday at $ 66.97 and has a 52 week low/high of $ 51.37 and $ 67.36.

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a line of health care products. Co. has four reportable segments: Established Pharmaceutical Products, which sells a line of branded generic pharmaceutical products internationally; Nutritional Products, which sells adult and pediatric nutritional products; Diagnostic Products, which sells diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites; and Vascular Products, which sells coronary, endovascular, structural heart, vessel closure and other medical device products. Non-reportable segments include the Diabetes Care and Medical Optics segments.

For more information on Abbott Laboratories click here.